Status:
NOT_YET_RECRUITING
The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery.
Lead Sponsor:
Cairo University
Conditions:
Emergence Agitation
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Emergence agitation is a postanesthetic phenomenon that develops in the early phase of recovery from general anesthesia, and is characterized by agitation, disorientation, confusion, and possible viol...
Eligibility Criteria
Inclusion
- All patients (male/female, American Society of Anesthesiologists physical status I-II, age: 18-60 years) undergoing elective nasal surgery will be eligible for the study.
Exclusion
- hypersensitivity to gabapentin
- patient refusal
- epilepsy
- neurological or psychological conditions that impair communication.
- current use of gabapentin, psychotropic or opioids medications.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT06887998
Start Date
March 1 2025
End Date
March 1 2026
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Elainy Hospital , Cairo University
Cairo, Cairo Governorate, Egypt, 11956